Select all docs (Max 200)
Narrow Results:
Publication Year
- 2024 48
- 2023 47
- 2022 92
- 2021 112
- 2020 46
- 2019 40
- 2018 38
- 2017 40
- 2016 27
- 2015 24
- 2014 27
- 2013 24
- 2012 14
- 2011 12
- 2010 7
- 2009 6
- 2008 3
- 2007 6
- 2006 5
- 2005 8
- 2004 7
- 2003 10
- 2002 6
- 2001 4
- 2000 6
- 1999 9
- 1998 4
- 1997 5
- 1996 5
- 1995 6
- 1994 5
- 1993 3
- 1992 2
- 1991 4
- 1990 3
- 1989 3
- 1988 3
- 1987 4
- 1986 5
- 1985 4
- 1984 4
- 1983 6
- 1982 5
- 1981 5
- 1980 5
- 1979 6
- 1978 5
- 1977 5
- 1976 8
- 1975 3
- 1974 5
- 1973 4
- 1972 5
- 1971 7
- 1970 7
- 1969 3
- 1968 3
- 1967 3
- 1966 3
- 1965 2
- 1964 1
- 1962 1
- 1959 2
- 1958 1
- 1957 2
- 1956 1
- 1955 4
- 1953 1
Medical Subject
- Vaccines (831)
Personal Author
- Allison, Mandy A. 6
- Ault, Kevin 4
- Baxter, Roger 3
- Beaty, Brenda L. 5
- Bell, Beth P. 5
- Bennett, Nancy M. 3
- Bernstein, Henry 4
- Black, Carla L. 3
- Bonhoeffer, Jan 4
- Bridges, Carolyn B. 9
- Britton, Amadea 4
- Brtnikova, Michaela 6
- Burnett, Eleanor 3
- Cardemil, Cristina 3
- Chen, Robert T. 6
- Chu, Susan Y. 4
- Cineas, Sybil 3
- Cohen, Adam L. 3
- Cohn, Amanda C. 11
- Cramer, Emily W. 4
- Crane, Lori A. 6
- Daley, Matthew F. 5
- DeStefano, Frank 7
- Diallo, Mamadou S. 5
- Dooling, Kathleen L. 3
- Duffy, Jonathan 5
- Dumolard, Laure 3
- Elam-Evans, Laurie D. 8
- Fiebelkorn, Amy Parker 3
- Fredua, Benjamin 3
- Frew, Paula M. 3
- Gacic-Dobo, Marta 4
- Gee, Julianne 5
- Gerlach, Ken 3
- Gessner, Bradford D. 3
- Glanz, Jason M. 5
- Goddard, Kristin 4
- Goodman, Tracey 3
- Goodson, James L. 3
- Hambidge, Simon J. 5
- Harris, LaTreace 3
- Hill, Holly A. 4
- Hills, Susan 5
- Hills, Susan L. 5
- Hunter, Paul 6
- Hurley, Laura P. 6
- Hyde, Terri B. 8
- Jackson, Lisa A. 3
- Jackson, Michael L. 3
- Jacobsen, Steven J. 3
- Jimenez-Zambrano, Andrea 4
- Kang, Yoonjae 3
- Kempe, Allison 9
- Kennedy, Erin D. 3
- Kennedy, Pamela 3
- Kim, David K. 7
- Klein, Nicola P. 9
- Kochhar, Sonali 4
- Kroger, Andrew T. 6
- Lambach, Philipp 3
- Lee, Grace M. 4
- Leidner, Andrew J. 5
- Lewis, Ned 3
- Lindley, Megan C. 6
- Loharikar, Anagha 4
- Lu, Peng-Jun 5
- Mantel, Carsten 5
- Markowitz, Lauri E. 6
- Marquez, Paige 6
- McLean, Huong Q. 3
- McNeil, Michael M. 5
- Messonnier, Mark 3
- Moen, Ann 4
- Moro, Pedro L. 6
- Murthy, Neil 5
- Myers, Tanya R. 3
- Naleway, Allison L. 3
- Oliver, Sara E. 5
- Omer, Saad B. 5
- Ortiz, Justin R. 4
- Outin-Blenman, Sajata 3
- O’Halloran, Alissa 3
- O’Leary, Sean T. 3
- Pickering, Larry K. 7
- Pilishvili, Tamara 5
- Prosser, Lisa A. 4
- Robinson, Candice L. 5
- Romero, José R. 10
- Shay, David K. 4
- Shimabukuro, Tom T. 7
- Singleton, James A. 8
- Stokley, Shannon 7
- Wallace, Aaron S. 9
- Weintraub, Eric S. 5
- Williams, Walter W. 7
- Wodi, A. Patricia 7
- Wolicki, JoEllen 6
- Yankey, David 10
- Zhang, Bicheng 4
- Zhou, Fangjun 4
Corporate Author
- 2016 Global NITAG Network Meeting Participants 1
- ACIP Adult Immunization Work Group 1
- ACIP Chikungunya Vaccines Work Group 1
- ACIP Child/Adolescent Immunization Work Group 2
- ACIP Evidence-Based Recommendations Work Group 1
- ACIP Evidence Based Recommendations Work Group 1
- American Academy of Family Physicians. 6
- American Academy of Pediatrics. 5
- BeSD Working Group 1
- CDC COVID-19 Emergency Response Team 1
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team. 3
- CDC COVID-19 Vaccine Task Force. 1
- CDC COVID-19 Vaccine Task Force Federal Entities Team 1
- Center for Disease Control 2
- Center for Disease Control (U.S.). Advisory Committee on Immunization Practices. 2
- Center for Disease Control (U.S.). Immunization Practices Advisory Committee. 29
- Center for Disease Control. 14
- Center for Global Health (U.S.) 1
- Center for Global Health (U.S.). Global Immunization Division. 3
- Center for Prevention Serives (U.S.). Immunization Division. Biologics Surveillance. 9
- Center for Surveillance, Epidemiology and Laboratory Services (U.S.) 1
- Centers for Disease Control & Prevention (U.S.). COVID-19 Response, Vaccine Task Force. Vaccine Confidence & Demand Team. Insights Unit. 3
- Centers for Disease Control (U.S.) 10
- Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. 35
- Centers for Disease Control and Prevention (U.S.) 83
- Centers for Disease Control and Prevention (U.S.), Office of Public Health Preparedness and Response., Division of Strategic National Stockpile. 1
- Centers for Disease Control and Prevention (U.S.). COVID-19 Response Vaccine Task Force. Vaccine Confidence & Demand Team. Insights Unit. 1
- Centers for Disease Control and Prevention (U.S.). Global Health Odyssey Museum. 2
- Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Clinician Outreach and Communication Activity. 1
- Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. 1
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 1
- Communicable Disease Center (U.S.) 1
- Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. 6
- Connecticut Department of Public Health. 1
- CoVPN 5002 COMPASS Study Team 1
- Div. of Bacterial Diseases 2
- Div. of Global Migration and Quarantine 2
- Div. of Viral Diseases 2
- Div. of Viral Hepatitis 2
- Division of Reproductive Health-Centers for Disease Control and Prevention (CDC). 1
- El Salvador Demographic Association (ADS) 1
- General Dynamics Information Technology. 1
- Global Comprehensive Vaccine-Preventable Disease Surveillance Working Group 1
- Global Rotavirus Surveillance Network Clinical Presentation Group 1
- Global TravEpiNet Consortium (GTEN) 1
- GSK Vaccines. 1
- Harvard Medical School. Mini-Sentinel PRISM Team. 1
- Immunization Services Div 1
- Immunization Services Div. 1
- Immunization Services Division, National Center for Immunization and Respiratory Diseases (proposed), CDC, Atlanta, GA 30333, USA. akroger@cdc.gov, 1
- Infectious Diseases Society of America. 1
- Influenza Div 1
- Influenza Div. 1
- Leidos, Inc, Atlanta, GA 1
- Leidos, Inc. 1
- Leidos Inc. 1
- Marshfield Clinic Research Institute 1
- Moderna (firm) 1
- Nancy Lee & Associates. 5
- National Association of County and City Health Officials. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) 3
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Epidemiologic Research and Innovations Branch. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. 2
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. 2
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. 4
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. Chikungunya Vaccines Work Group. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. 4
- National Center for Emerging Zoonotic and Infectious Diseases (U.S.) 1
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) 3
- National Center for Immunization and Respiratory Diseases (U.S.) 29
- National Center for Immunization and Respiratory Diseases (U.S.), Global Immunization Division. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. 3
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 29
- National Center for Immunization and Respiratory Diseases (U.S.). Global Immunization Division. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. 11
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Communications and Education Branch. 14
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Immunization Information Systems Support Branch. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. 6
- National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. 6
- National Center for Immunization and Respiratory Diseases. 1
- National Center for Immunizations and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. 1
- National Center for Immunizations and Respiratory Diseases (U.S.). Immunization Services Division. 1
- National Center for Prevention Serives (U.S.). Immunization Division. Biologics Surveillance. 1
- National Communicable Disease Center (U.S.) 4
- National Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. 10
- National Immunization Program (Centers for Disease Control and Prevention) 17
- United States. Advisory Committee on Immunization Practices. 248
- United States. Advisory Committee on Immunization Practices.. 2
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. 3
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. 13
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. 5
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. 18
- United States. Advisory Committee on Immunization Practices. Hib/Meningococcal Vaccines Work Group. 2
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. 2
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. 2
- Centers for Disease Control and Prevention (U.S.) 2
Place as Subject
- Afganistan 1
- Armenia 1
- Barcelona, Spain 1
- Bolivia 1
- California 3
- Canada 1
- Colorado 1
- Connecticut 1
- Costa Rica 2
- District of Columbia 1
- Egypt 1
- El Salvador 2
- European Union 1
- Florida 1
- France 2
- gau 1
- Georgia 4
- Germany 1
- Ghana 1
- Guam 1
- Hong Kong 2
- India 1
- Indonesia 1
- Israel 2
- Italy 1
- Japan 1
- Kansas 1
- Kenya 2
- Mexico 1
- Minnesota 1
- Nepal 1
- New Mexico 2
- New York 1
- New York City, NY 1
- North America 3
- North Carolina 1
- Ohio 1
- Panama 1
- Paraguay 1
- Puerto Rico 2
- South Carolina 1
- Tanzania 1
- Texas 2
- U.S. 5
- United Kingdom 1
- United States 180
- Venezuela 1
- Zambia 1
Resource Type General
- Agenda 76
- Book 4
- Figures 1
- Journal Article 254
- Journal Issue 14
- Letter 1
- Map 3
- Minutes 196
- Newsletter 5
- Pamphlet (or booklet) 76
- Poster 10
- Presentation 86
- Report 45
- Text 12
- Webpage 45
Resource Type Specific
- Annual Reports 5
- Bibliography 1
- Chronology 1
- Conference Publications 341
- Dispatch 1
- Fact Sheet 49
- Fact sheet 1
- Guidance 4
- Historical Article 1
- Infographic 4
- Social Media Cards 1
- Standards 1
- Statistics 38
- Tables 8
- Trading Cards 2
- Webinar 22
Keywords
- 2D barcode 1
- 2D barcode technology 1
- 2019 novel coronavirus disease 1
- Acute gastroenteritis (AGE) 1
- Adolescents 1
- Adult vaccination 2
- Adverse events 2
- Advisory Committee on Immunization Practices (ACIP) 1
- AEFI 2
- Ageing 1
- Alzheimer's disease 2
- Alzheimer's disease sequencing project 2
- Anthrax 1
- antiviral agents 2
- Attitudes 1
- BA.4/BA.5 strains 1
- Beyond vaccine efficacy 1
- Bivalent mRNA COVID-19 vaccine 1
- Brighton 1
- Burkholderia pseudomallei 1
- Case definitionsm 1
- Child 1
- Children 1
- Chlorination 4
- Clinician 1
- Comirnaty 1
- Conference report 1
- CoronaVac 1
- Coronavirus 1
- coronavirus disease 2
- Cost-benefit 1
- Costs 1
- COVID-19 7
- COVID-19 vaccination 1
- COVID-19 vaccine 1
- Drug user 1
- Economic Benefits 1
- epidemiology 2
- Epidemiology 1
- Equity 1
- Essential health services 1
- Evaluation 1
- Evidence-based decision-making 1
- Evidence-based recommendations 1
- Evidence-informed decision-making 1
- France 1
- Freeze dried vaccine 1
- Full public health value 1
- Genotype distribution 1
- Global Advisory Committee on Vaccine Safety 1
- Global health 2
- Global public health 1
- Hard-To-Reach 1
- Hard-to-reach 1
- Health Information Systems 1
- Health knowledge 1
- Health planning 1
- Health policy 1
- Health systems 1
- Health system strengthening 1
- Hepatitis A 1
- Hepatitis B 1
- herpes simplex 2
- HIV 1
- Household water treatment 4
- human papillomavirus 2
- Human resources 1
- IIS 1
- Immune senescence 1
- Immunization 7
- immunization 3
- Immunization policy 1
- Immunization program 1
- Immunization programmes 1
- Immunization programs 1
- Immunizations 1
- Japanese encephalitis vaccine 1
- Kenya 1
- Maternal immunization 3
- Pregnancy 4
- respiratory infections 2
- Safe water storage 4
- SARS-CoV-2 2
- severe acute respiratory syndrome coronavirus 2 2
- Surveillance 3
- torque teno viruses 2
- Vaccination 6
- vaccination 2
- Vaccine 2
- vaccine 2
- vaccine-preventable diseases 2
- Vaccine policy 3
- Vaccines 5
- vaccines 4
- Vaccine safety 10
- vaccine safety 2
- viruses 2
- whole exome sequencing 2
- whole genome sequencing 2
- zoonoses 2
x
Vaccines
Select all docs (Max 200)
1 -
20 of 831 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2024 (48)
- 2023 (47)
- 2022 (92)
- 2021 (112)
- 2020 (46)
- 2019 (40)
- 2018 (38)
- 2017 (40)
- 2016 (27)
- 2015 (24)
- 2014 (27)
- 2013 (24)
- 2012 (14)
- 2011 (12)
- 2010 (7)
- 2009 (6)
- 2008 (3)
- 2007 (6)
- 2006 (5)
- 2005 (8)
- 2004 (7)
- 2003 (10)
- 2002 (6)
- 2001 (4)
- 2000 (6)
- 1999 (9)
- 1998 (4)
- 1997 (5)
- 1996 (5)
- 1995 (6)
- 1994 (5)
- 1993 (3)
- 1992 (2)
- 1991 (4)
- 1990 (3)
- 1989 (3)
- 1988 (3)
- 1987 (4)
- 1986 (5)
- 1985 (4)
- 1984 (4)
- 1983 (6)
- 1982 (5)
- 1981 (5)
- 1980 (5)
- 1979 (6)
- 1978 (5)
- 1977 (5)
- 1976 (8)
- 1975 (3)
- 1974 (5)
- 1973 (4)
- 1972 (5)
- 1971 (7)
- 1970 (7)
- 1969 (3)
- 1968 (3)
- 1967 (3)
- 1966 (3)
- 1965 (2)
- 1964 (1)
- 1962 (1)
- 1959 (2)
- 1958 (1)
- 1957 (2)
- 1956 (1)
- 1955 (4)
- 1953 (1)
-
Vaccines (831)
- Allison, Mandy A. (6)
- Ault, Kevin (4)
- Baxter, Roger (3)
- Beaty, Brenda L. (5)
- Bell, Beth P. (5)
- Bennett, Nancy M. (3)
- Bernstein, Henry (4)
- Black, Carla L. (3)
- Bonhoeffer, Jan (4)
- Bridges, Carolyn B. (9)
- Britton, Amadea (4)
- Brtnikova, Michaela (6)
- Burnett, Eleanor (3)
- Cardemil, Cristina (3)
- Chen, Robert T. (6)
- Chu, Susan Y. (4)
- Cineas, Sybil (3)
- Cohen, Adam L. (3)
- Cohn, Amanda C. (11)
- Cramer, Emily W. (4)
- Crane, Lori A. (6)
- Daley, Matthew F. (5)
- DeStefano, Frank (7)
- Diallo, Mamadou S. (5)
- Dooling, Kathleen L. (3)
- Duffy, Jonathan (5)
- Dumolard, Laure (3)
- Elam-Evans, Laurie D. (8)
- Fiebelkorn, Amy Parker (3)
- Fredua, Benjamin (3)
- Frew, Paula M. (3)
- Gacic-Dobo, Marta (4)
- Gee, Julianne (5)
- Gerlach, Ken (3)
- Gessner, Bradford D. (3)
- Glanz, Jason M. (5)
- Goddard, Kristin (4)
- Goodman, Tracey (3)
- Goodson, James L. (3)
- Hambidge, Simon J. (5)
- Harris, LaTreace (3)
- Hill, Holly A. (4)
- Hills, Susan (5)
- Hills, Susan L. (5)
- Hunter, Paul (6)
- Hurley, Laura P. (6)
- Hyde, Terri B. (8)
- Jackson, Lisa A. (3)
- Jackson, Michael L. (3)
- Jacobsen, Steven J. (3)
- Jimenez-Zambrano, Andrea (4)
- Kang, Yoonjae (3)
- Kempe, Allison (9)
- Kennedy, Erin D. (3)
- Kennedy, Pamela (3)
- Kim, David K. (7)
- Klein, Nicola P. (9)
- Kochhar, Sonali (4)
- Kroger, Andrew T. (6)
- Lambach, Philipp (3)
- Lee, Grace M. (4)
- Leidner, Andrew J. (5)
- Lewis, Ned (3)
- Lindley, Megan C. (6)
- Loharikar, Anagha (4)
- Lu, Peng-Jun (5)
- Mantel, Carsten (5)
- Markowitz, Lauri E. (6)
- Marquez, Paige (6)
- McLean, Huong Q. (3)
- McNeil, Michael M. (5)
- Messonnier, Mark (3)
- Moen, Ann (4)
- Moro, Pedro L. (6)
- Murthy, Neil (5)
- Myers, Tanya R. (3)
- Naleway, Allison L. (3)
- Oliver, Sara E. (5)
- Omer, Saad B. (5)
- Ortiz, Justin R. (4)
- Outin-Blenman, Sajata (3)
- O’Halloran, Alissa (3)
- O’Leary, Sean T. (3)
- Pickering, Larry K. (7)
- Pilishvili, Tamara (5)
- Prosser, Lisa A. (4)
- Robinson, Candice L. (5)
- Romero, José R. (10)
- Shay, David K. (4)
- Shimabukuro, Tom T. (7)
- Singleton, James A. (8)
- Stokley, Shannon (7)
- Wallace, Aaron S. (9)
- Weintraub, Eric S. (5)
- Williams, Walter W. (7)
- Wodi, A. Patricia (7)
- Wolicki, JoEllen (6)
- Yankey, David (10)
- Zhang, Bicheng (4)
- Zhou, Fangjun (4)
- 2016 Global NITAG Network Meeting Participants (1)
- ACIP Adult Immunization Work Group (1)
- ACIP Chikungunya Vaccines Work Group (1)
- ACIP Child/Adolescent Immunization Work Group (2)
- ACIP Evidence-Based Recommendations Work Group (1)
- ACIP Evidence Based Recommendations Work Group (1)
- American Academy of Family Physicians. (6)
- American Academy of Pediatrics. (5)
- BeSD Working Group (1)
- CDC COVID-19 Emergency Response Team (1)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team. (3)
- CDC COVID-19 Vaccine Task Force. (1)
- CDC COVID-19 Vaccine Task Force Federal Entities Team (1)
- Center for Disease Control (2)
- Center for Disease Control (U.S.). Advisory Committee on Immunization Practices. (2)
- Center for Disease Control (U.S.). Immunization Practices Advisory Committee. (29)
- Center for Disease Control. (14)
- Center for Global Health (U.S.) (1)
- Center for Global Health (U.S.). Global Immunization Division. (3)
- Center for Prevention Serives (U.S.). Immunization Division. Biologics Surveillance. (9)
- Center for Surveillance, Epidemiology and Laboratory Services (U.S.) (1)
- Centers for Disease Control & Prevention (U.S.). COVID-19 Response, Vaccine Task Force. Vaccine Confidence & Demand Team. Insights Unit. (3)
- Centers for Disease Control (U.S.) (10)
- Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. (35)
- Centers for Disease Control and Prevention (U.S.) (83)
- Centers for Disease Control and Prevention (U.S.), Office of Public Health Preparedness and Response., Division of Strategic National Stockpile. (1)
- Centers for Disease Control and Prevention (U.S.). COVID-19 Response Vaccine Task Force. Vaccine Confidence & Demand Team. Insights Unit. (1)
- Centers for Disease Control and Prevention (U.S.). Global Health Odyssey Museum. (2)
- Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Clinician Outreach and Communication Activity. (1)
- Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. (1)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (1)
- Communicable Disease Center (U.S.) (1)
- Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. (6)
- Connecticut Department of Public Health. (1)
- CoVPN 5002 COMPASS Study Team (1)
- Div. of Bacterial Diseases (2)
- Div. of Global Migration and Quarantine (2)
- Div. of Viral Diseases (2)
- Div. of Viral Hepatitis (2)
- Division of Reproductive Health-Centers for Disease Control and Prevention (CDC). (1)
- El Salvador Demographic Association (ADS) (1)
- General Dynamics Information Technology. (1)
- Global Comprehensive Vaccine-Preventable Disease Surveillance Working Group (1)
- Global Rotavirus Surveillance Network Clinical Presentation Group (1)
- Global TravEpiNet Consortium (GTEN) (1)
- GSK Vaccines. (1)
- Harvard Medical School. Mini-Sentinel PRISM Team. (1)
- Immunization Services Div (1)
- Immunization Services Div. (1)
- Immunization Services Division, National Center for Immunization and Respiratory Diseases (proposed), CDC, Atlanta, GA 30333, USA. akroger@cdc.gov, (1)
- Infectious Diseases Society of America. (1)
- Influenza Div (1)
- Influenza Div. (1)
- Leidos, Inc, Atlanta, GA (1)
- Leidos, Inc. (1)
- Leidos Inc. (1)
- Marshfield Clinic Research Institute (1)
- Moderna (firm) (1)
- Nancy Lee & Associates. (5)
- National Association of County and City Health Officials. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) (3)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Epidemiologic Research and Innovations Branch. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. (2)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. (2)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. (4)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. Chikungunya Vaccines Work Group. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. (4)
- National Center for Emerging Zoonotic and Infectious Diseases (U.S.) (1)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) (3)
- National Center for Immunization and Respiratory Diseases (U.S.) (29)
- National Center for Immunization and Respiratory Diseases (U.S.), Global Immunization Division. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. (3)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (29)
- National Center for Immunization and Respiratory Diseases (U.S.). Global Immunization Division. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. (11)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Communications and Education Branch. (14)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Immunization Information Systems Support Branch. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (6)
- National Center for Immunization and Respiratory Diseases (U.S.)Immunization Services Division. (6)
- National Center for Immunization and Respiratory Diseases. (1)
- National Center for Immunizations and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. (1)
- National Center for Immunizations and Respiratory Diseases (U.S.). Immunization Services Division. (1)
- National Center for Prevention Serives (U.S.). Immunization Division. Biologics Surveillance. (1)
- National Communicable Disease Center (U.S.) (4)
- National Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. (10)
- National Immunization Program (Centers for Disease Control and Prevention) (17)
- United States. Advisory Committee on Immunization Practices. (248)
- United States. Advisory Committee on Immunization Practices.. (2)
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. (3)
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. (13)
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. (5)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. (18)
- United States. Advisory Committee on Immunization Practices. Hib/Meningococcal Vaccines Work Group. (2)
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. (2)
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. (2)
- Centers for Disease Control and Prevention (U.S.) (2)
- Afganistan (1)
- Armenia (1)
- Barcelona, Spain (1)
- Bolivia (1)
- California (3)
- Canada (1)
- Colorado (1)
- Connecticut (1)
- Costa Rica (2)
- District of Columbia (1)
- Egypt (1)
- El Salvador (2)
- European Union (1)
- Florida (1)
- France (2)
- gau (1)
- Georgia (4)
- Germany (1)
- Ghana (1)
- Guam (1)
- Hong Kong (2)
- India (1)
- Indonesia (1)
- Israel (2)
- Italy (1)
- Japan (1)
- Kansas (1)
- Kenya (2)
- Mexico (1)
- Minnesota (1)
- Nepal (1)
- New Mexico (2)
- New York (1)
- New York City, NY (1)
- North America (3)
- North Carolina (1)
- Ohio (1)
- Panama (1)
- Paraguay (1)
- Puerto Rico (2)
- South Carolina (1)
- Tanzania (1)
- Texas (2)
- U.S. (5)
- United Kingdom (1)
- United States (180)
- Venezuela (1)
- Zambia (1)
- 2D barcode (1)
- 2D barcode technology (1)
- 2019 novel coronavirus disease (1)
- Acute gastroenteritis (AGE) (1)
- Adolescents (1)
- Adult vaccination (2)
- Adverse events (2)
- Advisory Committee on Immunization Practices (ACIP) (1)
- AEFI (2)
- Ageing (1)
- Alzheimer's disease (2)
- Alzheimer's disease sequencing project (2)
- Anthrax (1)
- antiviral agents (2)
- Attitudes (1)
- BA.4/BA.5 strains (1)
- Beyond vaccine efficacy (1)
- Bivalent mRNA COVID-19 vaccine (1)
- Brighton (1)
- Burkholderia pseudomallei (1)
- Case definitionsm (1)
- Child (1)
- Children (1)
- Chlorination (4)
- Clinician (1)
- Comirnaty (1)
- Conference report (1)
- CoronaVac (1)
- Coronavirus (1)
- coronavirus disease (2)
- Cost-benefit (1)
- Costs (1)
- COVID-19 (7)
- COVID-19 vaccination (1)
- COVID-19 vaccine (1)
- Drug user (1)
- Economic Benefits (1)
- epidemiology (2)
- Epidemiology (1)
- Equity (1)
- Essential health services (1)
- Evaluation (1)
- Evidence-based decision-making (1)
- Evidence-based recommendations (1)
- Evidence-informed decision-making (1)
- France (1)
- Freeze dried vaccine (1)
- Full public health value (1)
- Genotype distribution (1)
- Global Advisory Committee on Vaccine Safety (1)
- Global health (2)
- Global public health (1)
- Hard-To-Reach (1)
- Hard-to-reach (1)
- Health Information Systems (1)
- Health knowledge (1)
- Health planning (1)
- Health policy (1)
- Health systems (1)
- Health system strengthening (1)
- Hepatitis A (1)
- Hepatitis B (1)
- herpes simplex (2)
- HIV (1)
- Household water treatment (4)
- human papillomavirus (2)
- Human resources (1)
- IIS (1)
- Immune senescence (1)
- Immunization (7)
- immunization (3)
- Immunization policy (1)
- Immunization program (1)
- Immunization programmes (1)
- Immunization programs (1)
- Immunizations (1)
- Japanese encephalitis vaccine (1)
- Kenya (1)
- Maternal immunization (3)
- Pregnancy (4)
- respiratory infections (2)
- Safe water storage (4)
- SARS-CoV-2 (2)
- severe acute respiratory syndrome coronavirus 2 (2)
- Surveillance (3)
- torque teno viruses (2)
- Vaccination (6)
- vaccination (2)
- Vaccine (2)
- vaccine (2)
- vaccine-preventable diseases (2)
- Vaccine policy (3)
- Vaccines (5)
- vaccines (4)
- Vaccine safety (10)
- vaccine safety (2)
- viruses (2)
- whole exome sequencing (2)
- whole genome sequencing (2)
- zoonoses (2)
- :Centers for Disease Control and Prevention (U.S.)11/05/2021:To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for...
- :Centers for Disease Control and Prevention (U.S.)11/02/2021:Prepare the injection with the correct needle length based on the recipient’s age.Gender and weight should be considered for adults 19 years of age ...
- :Centers for Disease Control and Prevention (U.S.)10/29/2021:To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for...
- :Centers for Disease Control and Prevention (U.S.)10/29/2021:To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for...
- :Centers for Disease Control and Prevention (U.S.)10/27/2021:To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for...
- :Centers for Disease Control and Prevention (U.S.)10/28/2021:To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for...
- :National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.Oct. 28, 2021:Updated Oct. 28, 2021Pfizer-BioNTech (COMIRNATY) Name ChangePfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on A...
- :National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.Oct. 16, 2021:Updated Oct. 16, 2021Pfizer-BioNTech (COMIRNATY) Name ChangePfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on A...
- :Music, Nedzad ;Tzeng, Wen-PinJuly 09 2019 | NPJ Vaccines. 4:Epidemiological studies suggest that humans who receive repeated annual immunization with influenza vaccine are less well protected against influenza ...
- :Wolicki, JoEllenJuly 8, 2020 | EpiVac Pink book Web-on-demand series:CDC is offering a series of weekly one-hour web-on-demand videos that will provide an overview of vaccination principles, general best practices, immu...
- :Mbaeyi, Chukwuma ;Kamawal, Noor ShahJul 01 2017 | J Infect Dis. 2017; 216(Suppl 1):S273-S279.:Background.The Basic Package of Health Services (BPHS) program has increased access to immunization services for children living in rural Afghanistan....
- :Lindley, Megan C. ;Hurley, Laura P.Feb 14 2018 | Vaccine. 36(8):1093-1100:BackgroundFinancial concerns are often cited by physicians as a barrier to administering routinely recommended vaccines to adults. The purpose of this...
- :Objio, TinaJuly 1, 2020 | EpiVac Pink book Web-on-demand series:CDC is offering a series of weekly one-hour web-on-demand videos that will provide an overview of vaccination principles, general best practices, immu...
- 01/07/2021:Vaccine Administration: Dry Ice Safety for Healthcare ProfessionalsDry Ice Safety for Healthcare Professionals. Never handle dry ice with bare hands. ...
- :Centers for Disease Control and Prevention (U.S.)March 2021:The Vaccine Storage and Handling Toolkit has been updated with an addendum to address proper storage, handling, transport, and emergency handling of C...
- :Harmon, Jessica R. ;Barbeau, Dominique J.February 28 2020 | NPJ Vaccines. 5:Rift Valley fever virus (RVFV) is a zoonotic arbovirus of clinical significance in both livestock and humans. A formalin-inactivated virus preparation...
- :Jauregui, Barbara ;Garcia, Ana Gabriela FelixMay 07 2015 | Vaccine. 33(0 1):A28-A33:IntroductionPan American Health Organization’s (PAHO) ProVac Initiative aims to strengthen countries’ technical capacity to make evidence-based im...
- :Toscano, C.M. ;Vijayaraghavan, M.Jul 2 2013 | Vaccine. 31(0 3):C88-C93.:IntroductionFollowing World Health Organization recommendations set forth in the Global Framework for Immunization Monitoring and Surveillance, Costa ...
- :Hyde, Terri B. ;Andrus, Jon K.Jul 2 2013 | Vaccine. 31(0 3):C94-C98.:In 2007, the World Health Organization published the Global Framework for Immunization Monitoring and Surveillance (GFIMS) outlining measures to enhan...
- :Robinson, Chester A. ;Evans, Willard B.1994 Sep-Oct | Public Health Rep. 109(5):594-600:President Clinton submitted the Comprehensive Childhood Immunization Initiative Act to Congress in April 1993. The objective of the legislation is to ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.